Targeted Natural Killer (NK) Cell Based Adoptive Immunotherapy for the Treatment of Patients With Non-Small Cell Lung Cancer (NSCLC) After Radiochemotherapy (RCT)
Clinical trial NCT02118415 · COMPLETED
Trial details
- NCT number
- NCT02118415
- Sponsor
- Technical University of Munich
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2018-03-28
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.